C12N 2760/18632
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2760/18632 (Use of virus as therapeutic agent, other than vaccine) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 1
- Inventors
- 1
- Latest grant
- 2 Oct 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
By publication year.
Recent patents
- Tissue targeted antigenic activation of the immune response to treat cancers2 Oct 2018US 10,086,066 B2Qu Biologics Inc.
- Tissue targeted antigenic activation of the immune response to treat cancers3 Oct 2017US 9,775,896 B2Qu Biologics Inc.
- Tissue targeted antigenic activation of the immune response to treat cancers18 Aug 2015US 9,107,864 B2Qu Biologics Inc.
- Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers23 Apr 2020US 2020/0121784 A1Qu Biologics Inc.
- Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers28 Dec 2017US 2017/0368166 A1Qu Biologics Inc.
- Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers15 Sep 2016US 2016/0263209 A1Qu Biologics Inc.
- Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers3 Dec 2015US 2015/0343050 A1Qu Biologics Inc.
- Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers11 Aug 2011US 2011/0195093 A1Qu Biologics Inc.
Most cited
By later US patents
- Tissue targeted antigenic activation of the immune response to treat cancers13US 9,107,864 B2Qu Biologics Inc. · 2015
- Tissue targeted antigenic activation of the immune response to treat cancers5US 9,775,896 B2Qu Biologics Inc. · 2017
- Tissue targeted antigenic activation of the immune response to treat cancers2US 10,086,066 B2Qu Biologics Inc. · 2018